Additional file 2: of Opportunities and challenges in incorporating ancillary studies into a cancer prevention randomized clinical trial

P. Goodman (Creator)
Catherine M. Tangen (Creator)
Amy K. Darke (Creator)
Kathryn B. Arnold (Creator)
Jo Ann Hartline (Creator)
Monica Yee (Creator)
Karen Anderson (Creator)
Allison Caban-Holt (Creator)
William G. Christen (Creator)
Patricia A. Cassano (Creator)
Peter Lance (Creator)
Eric A. Klein (Creator)
John J. Crowley (Creator)
Lori Minasian (Creator)
Frank L. Meyskens (Creator)

Dataset

Description

Participating IRBs on SELECT. (XLS 81 kb)

Date made available	2016
Publisher	figshare

DOI
10.6084/m9.figshare.c.3631349_d2

Access Dataset

CC BY + CC0

Opportunities and challenges in incorporating ancillary studies into a cancer prevention randomized clinical trial
Goodman, P. J., Tangen, C. M., Darke, A. K., Arnold, K. B., Hartline, J. A., Yee, M., Anderson, K., Caban-Holt, A., Christen, W. G., Cassano, P. A., Lance, P., Klein, E. A., Crowley, J. J., Minasian, L. M. & Meyskens, F. L., Aug 12 2016, In: Trials. 17, 1, 400.
Research output: Contribution to journal › Article › peer-review

Open Access
1 Link opens in a new tab Scopus citations

Cite this

DataSetCite

Goodman, P. J. (Creator), Tangen, C. M. (Creator), Darke, A. K. (Creator), Arnold, K. B. (Creator), Hartline, J. (Creator), Yee, M. (Creator), Anderson, K. (Creator), Caban-Holt, A. (Creator), Christen, W. G. (Creator), Cassano, P. A. (Creator), Lance, P. (Creator), Klein, E. A. (Creator), Crowley, J. J. (Creator), Minasian, L. M. (Creator), Meyskens, F. L. (Creator) (2016). Additional file 2: of Opportunities and challenges in incorporating ancillary studies into a cancer prevention randomized clinical trial. figshare. 10.6084/m9.figshare.c.3631349_d2

Additional file 2: of Opportunities and challenges in incorporating ancillary studies into a cancer prevention randomized clinical trial

Description

DOI

Access Dataset

Research output

Opportunities and challenges in incorporating ancillary studies into a cancer prevention randomized clinical trial

Cite this